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Dear Sir, 
 
We have read with interest Dr Kaić´s letter in January 27th issue of your journal 
regarding our study on virologically confirmed cases of aseptic meningitis (AM) following 
Leningrad-Zagreb (L-Z) mumps strain primovaccination (1, 2).  
As we understood, Dr Kaić´s criticism is focused on two points: (a) the study is 
hospital-based and (b) the authors do not know the precise denominator (1).  
Although, according to Dr Kaić´s statement, „the incidence rates cannot be derived 
from hospital-based data“, hospital-based incidence data have been a valuable source of 
information for many years and for many different disorders ranging from diarrhoea to stroke. 
A quick PubMed search reveals 8794 citations on hospital based incidence data. There are 
also several studies on the incidence of postvaccinal AM following MMR vaccination, that 
were partly, or fully hospital-based (3, 4, 5). Dr Miller´s study which included hospital data 
from the Oxford region, England, and the Fujinaga study based on hospital data from Gunma 
Prefecture, Japan were crucial in lightening the problem of postvaccinal AM after Urabe Am 
9 mumps strain vaccination (4, 5). Investigating the incidence of AM after MMR 
immunization with Urabe containing vaccine using new method for active post-marketing 
surveillance of vaccine safety based on patient records in England, Farrington finds similar 
postvaccinal AM incidence as the Oxford study (6). So, the problem, from our point of view, 
is not hospital source of data, but methodology (active versus passive surveillance) used in 
calculating the incidence of postvaccinal events. Passive reporting of postvaccinal adverse 
events severely underestimates the true incidence of postvaccinal AM (4, 7). Comparing the  
incidence of postvaccinal AM in the Zagreb metropolitan area that we found by active 
surveillance in the 8-year period with the data from the rest of Croatia based on passive 
surveillance, what dr Kaić has done, is simply wrong.  The comparison of data from active 
surveillance with data based on passive reporting of adverse events is methodologically 
incorrect and does not permit one to conclude that the majority of AM cases in Croatia 
happened in one fourth of the national population. The figures that Dr Kaić has cited can be 
used to support our opinion that AM following L-Z vaccination is not a rare event but rarely 
recognized by clinicians outside Zagreb and thus significantly underreported.  
Dr. Kaić claims that we do not know the denominator. This statement is probably 
based on the speculation that „it is not only persons from the Zagreb area who get to be 
hospitalized in the University hospital“ (1). We can, of course, confirm that our hospital 
serves as a tertiary care facility for infectious diseases for the whole Croatian population, but 
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it primarily serves the Zagreb metropolitan area. In describing the design of our study we 
stated that „all patients came from the Zagreb metropolitan area“. This means that all children 
with AM following mumps vaccination with L-Zagreb diagnosed at our institution who did 
not reside in the Zagreb metropolitan area were excluded from the study. Therefore, the 
incidence of postvaccinal AM was calculated based on the number of vacinees in Zagreb and 
its vicinity (2). Kaić´s argument on unknown or faulty denominator therefore does not stand.  
 In conclusion, in our recent prospective investigation performed for the Zagreb 
metropolitan area, postvaccinal AM was diagnosed by detection of the vaccine virus in 
cerebrospinal fluid and a well defined denominator was used for calculating the incidence 
rate. By doing so we overcame the disadvantages of our previous retrospective study (8). If 
our incidence rate of postvaccinal AM following L-Z immunization is questionable for the 
Croatian health care authorities, our results can be checked in a national-based study. 
However, in correct assessment of postvaccinal AM incidence, exact diagnosis of meningitis, 
as well as active surveillance are necessary. 
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